Clinical Trial

A Study of a Side Effects and Resource Navigation Program for People With Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to find out if the navigation program helps participants manage immunotherapy treatment better than usual care. Investigators will also look at how the navigation program impacts participants' quality of life. Investigators will measure quality of life by having participants complete questionnaires.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-09.
Trial Details
NCT Number NCT07646847
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Kidney Cancer, Bladder Cancer, Breast Cancer, Lung Cancer
Enrollment 200 participants
Start Date 2026-09-14
Primary Completion 2029-06-09 (estimated)
Study Completion 2029-06-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-31